Trial to Evaluate Efficacy and Safety of Pembrolizumab and Gemcitabine in HER2-negative ABC
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: Pembrolizumab|DRUG: Gemcitabine
Sponsor: Spanish Breast Cancer Research Group
Collaborators: Merck Sharp & Dohme LLC